Royalty Pharma Plc Stock Math Transform Price Natural Logarithm
RPRX Stock | USD 25.54 0.14 0.55% |
Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Royalty Pharma Price Natural Logarithm is logarithm with base 'e' where e is equal to 2.718281828. It is applied on the entire Royalty Pharma Plc pricing series.
Royalty Pharma Technical Analysis Modules
Most technical analysis of Royalty Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Royalty from various momentum indicators to cycle indicators. When you analyze Royalty charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Royalty Pharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Royalty Pharma Plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Royalty Pharma Plc based on widely used predictive technical indicators. In general, we focus on analyzing Royalty Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Royalty Pharma's daily price indicators and compare them against related drivers, such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Royalty Pharma's intrinsic value. In addition to deriving basic predictive indicators for Royalty Pharma, we also check how macroeconomic factors affect Royalty Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0173 | 0.0193 | 0.0285 | 0.0361 | Price To Sales Ratio | 7.22 | 7.74 | 5.34 | 5.07 |
Align your values with your investing style
In addition to having Royalty Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Banking Invested over 40 shares | ||
Driverless Cars Invested over 50 shares | ||
Momentum Invested over 200 shares | ||
Business Services Invested few shares | ||
Adviser Favorites Invested few shares | ||
Impulse Invested few shares | ||
Macroaxis Index Invested few shares | ||
FinTech Invested few shares | ||
Technology Invested few shares | ||
Millennials Best Invested few shares | ||
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.